Literature DB >> 11082162

Salt, blood pressure, and human health.

M H Alderman1.   

Abstract

The positive relation of sodium intake and blood pressure, first recognized a century ago, has been well established in ecological, epidemiological, and experimental human studies. Equally well established is the association of increasing blood pressure and cardiovascular morbidity and mortality. Indeed, the pharmacological capacity to reduce blood pressure has produced one of the great public health accomplishments of the 20th century. These two facts-the positive relation of blood pressure to strokes and heat attacks and the positive association of sodium intake to blood pressure-underlie the hypothesis that a reduction in sodium intake, by virtue of its hypotensive effect, might prevent strokes and heart attacks. Moreover, even if the effect on blood pressure were in the range of a 1- to 2-mm Hg decline in blood pressure for every 75- to 100-mmol difference in sodium intake, the impact of such a change, applied to the whole population, would be enormous. The problem with this appealing possibility is that a reduction in salt consumption of this magnitude has other-and sometimes adverse-health consequences. The question, therefore, is whether the beneficial hypotensive effects of sodium restriction will outweigh its hazards. Unfortunately, few data link sodium intake to health outcomes, and that which is available is inconsistent. Without knowledge of the sum of the multiple effects of a reduced sodium diet, no single universal prescription for sodium intake can be scientifically justified.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082162     DOI: 10.1161/01.hyp.36.5.890

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

2.  Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.

Authors:  Liliya M Yamaleyeva; Sarah H Lindsey; Jasmina Varagic; Li Li Zhang; Patricia E Gallagher; Alex F Chen; Mark C Chappell
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

3.  Renin-angiotensin system genes and exercise training-induced changes in sodium excretion in African American hypertensives.

Authors:  Jennifer M Jones; Jung-Jun Park; Jennifer Johnson; Dave Vizcaino; Brian Hand; Robert Ferrell; Matthew Weir; Thomas Dowling; Thomas Obisesan; Michael Brown
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

4.  Impaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC, and NAD(P)H oxidase.

Authors:  An Huang; Changdong Yan; Nobuhiro Suematsu; Azita Cuevas; Yang-Ming Yang; Elizabeth Kertowidjojo; Thomas H Hintze; Gabor Kaley; Dong Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

5.  ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.

Authors:  Chuanming Xu; Fei Wang; Yanting Chen; Shiying Xie; Danielle Sng; Bruno Reversade; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

6.  Drinking Water Salinity and Maternal Health in Coastal Bangladesh: Implications of Climate Change.

Authors:  Aneire Ehmar Khan; Andrew Ireson; Sari Kovats; Sontosh Kumar Mojumder; Amirul Khusru; Atiq Rahman; Paolo Vineis
Journal:  Environ Health Perspect       Date:  2011-04-12       Impact factor: 9.031

7.  Prevalence and correlation of hypertension among adult population in Bahir Dar city, northwest Ethiopia: a community based cross-sectional study.

Authors:  Zelalem Alamrew Anteneh; Worku Awoke Yalew; Dereje Birhanu Abitew
Journal:  Int J Gen Med       Date:  2015-05-06

8.  Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-12

9.  Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea.

Authors:  Andrew E Beaudin; Matiram Pun; Christina Yang; David D M Nicholl; Craig D Steinback; Donna M Slater; Katherine E Wynne-Edwards; Patrick J Hanly; Sofia B Ahmed; Marc J Poulin
Journal:  J Am Heart Assoc       Date:  2014-05-09       Impact factor: 5.501

10.  Stepped-wedge cluster-randomised controlled trial to assess the cardiovascular health effects of a managed aquifer recharge initiative to reduce drinking water salinity in southwest coastal Bangladesh: study design and rationale.

Authors:  Abu Mohd Naser; Leanne Unicomb; Solaiman Doza; Kazi Matin Ahmed; Mahbubur Rahman; Mohammad Nasir Uddin; Shamshad B Quraishi; Shahjada Selim; Mohammad Shamsudduha; William Burgess; Howard H Chang; Matthew O Gribble; Thomas F Clasen; Stephen P Luby
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.